| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |